Asrapime T 250mg/31.25mg Injection
Marketer
Asrawell Lifecare
Salt Composition
Cefepime (250mg) + Tazobactum (31.25mg)
Overview Asrapime T 250mg/31.25mg Injection
Combipime, a 250mg/31.25mg injectable antibiotic blend, combats diverse bacterial infections by hindering microbial proliferation. Administer this medication strictly under a doctor's guidance; adhere to all scheduled doses, completing the full course regardless of symptom improvement. Common side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions (redness, swelling, pain) may occur but typically resolve. Report worsening side effects immediately. Seek immediate medical attention for allergic reactions (rashes, itching, swelling, breathing difficulty). Inform your physician of all current medications, and pregnant or breastfeeding individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not affecting driving ability, refrain from driving if drowsiness or dizziness occurs.
Uses of Asrapime T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Asrapime T 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; please do not attempt self-medication.
Common Side effects of Asrapime T 250mg/31.25mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Asrapime T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Asrapime T 250mg/31.25mg Injection works:
Asrapime T Injection (250mg/31.25mg) combines the antibiotic cefepime with the beta-lactamase inhibitor tazobactam. Cefepime disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counteracts bacterial enzymes that would otherwise degrade cefepime, thus broadening cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Asrapime T 250mg/31.25mg Injection with alcohol. Seek medical advice.
PregnancySAFE IF PRESCRIBED
The injectable medication Asrapime T 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Asrapime T 250mg/31.25mg injections pose minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, signifying no appreciable harm to infants.
DrivingUNSAFE
Following administration of Asrapime T 250mg/31.25mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
The injectable medication Asrapime T (250mg/31.25mg) requires careful administration for individuals with impaired kidney function. Dosage modification may be necessary; physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Asrapime T 250mg/31.25mg Injection appears to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification of Asrapime T 250mg/31.25mg Injection may be unnecessary in such cases. Physician consultation is recommended.
What if you forget to take Asrapime T 250mg/31.25mg Injection :
Omitting a scheduled dose of Asrapime T 250mg/31.25mg Injection warrants immediate physician consultation.
Facts to Know About Asrapime T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | Agents against infection |
3,018 People bought this recently